1Spieker LE,Noll G,Ruschitzka FT,et al.Endothelin receptor antagonists in congestive heart failure:a new therapeutic principle for the future[J]?J Am Coll Cardiol,2001,37:1493-1505.
2Kalra PR,Moon JC,Coats AJ.Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure[J]?Int J Cardiol,2002,85:195-197.
3Kostis JB,Packer M,Black HR,et al.Omapatrilat and enalapril in patients with hypertension:the Omapatrilat Cardiovascular Treatment vs.Enalapril (OCTAVE) trial[J].Am J Hypertens,2004,17:103-111.
4Gheorghiade M,Niazi I,Ouyang J,et al.Vasopressin V2-Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure[J].Circulation,2003,107:2690-2696.
5Pitt B.A New Hope for Aldosterone Blockade[J].Circulation,2004,110:1714-1716.
6Pitt B,Remme W,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348:1309-1321.
7Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting(from the FUSIONⅠtrial)[J].Am J Cardiol,2004,94:595-601.
8Mitchell GF,Arnold JM,Dunlap ME,et al.Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure:The CHARM Program[J].Eur J Heart Fail,2006,8:191-197.
9Horwich TB,MacLellan WR,Fonarow GC.Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure[J].J Am Coll Cardiol,2004,43:642-648.
10Node K.Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy[J].Circulation,2003,108:839-843.
